Literature DB >> 24909124

Clinical and radiological findings in methadone-induced delayed leukoencephalopathy.

Indre Bileviciute-Ljungar1, Vera Häglund, Jenny Carlsson, Anders von Heijne.   

Abstract

OBJECTIVE: To increase awareness of the incidence of delayed leukoencephalopathy in rehabilitation medicine. SUBJECT: A 34-year-old male patient in an inpatient neuro-rehabilitation clinic who developed cognitive, psychological and physical deterioration 33 days after methadone intake.
METHODS: Clinical follow-up for 7 months, brain imaging with magnetic resonance imaging and computed tomography, electroencephalography, multidisciplinary team evaluation and rehabilitation, pharmacological treatment, and examination of medical records.
RESULTS: Clinical findings showed neuropsychological and motor deterioration. Brain images demonstrated that previous white matter infarctions had developed to cystic substance defects, and that abnormally high signals developed in the white matter of most cerebral lobes, with the exception of the grey matter and the cerebellum. Clinical improvement coincided with a modification in pharmacological treatment (increase in sertraline and introduction of baclofen). Brain images at 3 and 6 months after the methadone overdose showed reduced intensity of signal abnormalities and complete normalization of diffusion weighted images. Evaluation 7 months after injury estimated moderate brain injury with moderate disability and partial recovery of the patient's capacity for previous activities of daily living.
CONCLUSION: Delayed leukoencephalopathy should be suspected in patients who deteriorate after methadone overdose. Drugs such as sertraline and baclofen may be of use in treating delayed leukoencephalopathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24909124     DOI: 10.2340/16501977-1820

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  6 in total

1.  Methadone use in a male with the FMRI premutation and FXTAS.

Authors:  Zukhrofi Muzar; Reymundo Lozano; Andrea Schneider; Patrick E Adams; Sultana M H Faradz; Flora Tassone; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

2.  Opioid-Induced Leukoencephalopathies: A Report of Two Cases.

Authors:  Gustav Højrup Knudsen; Nata Kermanian; Carsten Hanshelge Kock-Jensen; Ronald Antulov
Journal:  Case Rep Neurol       Date:  2022-02-01

3.  Methadone-induced Damage to White Matter Integrity in Methadone Maintenance Patients: A Longitudinal Self-control DTI Study.

Authors:  Wei Li; Qiang Li; Yarong Wang; Jia Zhu; Jianjun Ye; Xuejiao Yan; Yongbin Li; Jiajie Chen; Jierong Liu; Zhe Li; Wei Wang; Yijun Liu
Journal:  Sci Rep       Date:  2016-01-22       Impact factor: 4.379

4.  Delayed Posthypoxic Leukoencephalopathy: Improvement with Antioxidant Therapy.

Authors:  Franklin King; Nicholas A Morris; Jeremy D Schmahmann
Journal:  Case Rep Neurol       Date:  2015-12-24

5.  Methadone-induced encephalopathy: a case series and literature review.

Authors:  Maryam Haghighi-Morad; Zahra Naseri; Nazila Jamshidi; Hossein Hassanian-Moghaddam; Nasim Zamani; Leila Ahmad-Molaei
Journal:  BMC Med Imaging       Date:  2020-01-17       Impact factor: 1.930

Review 6.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.